We are at the cusp of a stem cell revolution. Understanding and harnessing these unique cells may unlock breakthroughs in longevity and therapeutic solutions to all kinds of chronic diseases and regenerative opportunities.
Stem cells are a type of cell that holds the potential to differentiate into different cell types and self-renew. The interest in stem cells in the medical field is at an all-time high.
While a considerable amount of data exists for clinical trials and laboratory performance for non-invasive prenatal testing (NIPT) of autosomal aneuploidies (chromosomal abnormalities), relatively little data is available on laboratory performance for sex chromosome aneuploidies.
Exciting clinical work continues in transplant medicine and mesenchymal stem cell therapy. Recent studies from China highlight the co-transplantation of umbilical cord mesenchymal stem cells (UC-MSC) and umbilical cord blood haematopoietic stem cells (CB-HSC).
Next Biosciences’ role in developing FirstScreen with North-West University is to establish a newborn screening programme that is widely accessible to South African doctors and patients.
Act now to give your baby the best chance for a healthy future. Learn about newborn screening and how it can detect serious conditions early on.
We started discussing the form our corporate social investment would take well over a year ago.
There enormous growth in perinatal stem cell research, particularly the non-haematological uses of both cord blood and cord tissue stem cells.
Current academic views on cord blood banking are still conservative as the lifetime likelihood of developing a blood-related disease requiring transplantation remains low.
According to a recent article in Live Science, human amniotic membrane biological patches can be used to treat superficial wounds such as partial thickness burn wounds, diabetic foot ulcers, venous leg ulcers and bed sores.
